By National Brain Tumor Society Joint initiatives aim to help patients and families navigate the era of precision medicine in cancer care
|
By Cures Within Reach Cures Within Reach partnered with Goldman Philanthropic Partnerships, Leukemia Research Foundation and individual donors to fund these pivotal trials
|
 | By OncoBeta GmbH OncoBeta® GmbH, a medical device company specialised in innovative epidermal radioisotope therapies, has confirmed the phase IV international multi-centre study designed to further evaluate the Complete Response Rate of patients with non-melanoma skin...
|
By Veterinary Health Research Centers LLC Veterinary Health Research Centers Finalist for Citeline's Most Innovative Start-up Company Award
|
 | By Elixia Sam Searcy joins Elixia, a site management organization, to oversee and increase business growth.
|
By Scott PR Clinical trial management solutions provider, encapsia, has announced the appointment of Francis Destin as its new Chief Operating Officer.
|
By SiteBridge Research Expanding access to care for medically underserved populations
|
 | By Cures Within Reach Clinical Repurposing Trials in Bladder Cancer and Seizures after Cardiac Arrest Receive Funding
|
By WideTrial Basket trial of neoantigen synthetic long peptide vaccines for patients with advanced malignancy, run by the Jaime Leandro Foundation in association with Washington University of St. Louis
|
By SocraTec R&D GmbH Socratec R&D, a German full-service CRO with strong expertise in early phase clinical trials, receives CIR accreditation as a research institute recognised by the French government.
|
By Cures Within Reach Ten clinical trials starting soon in Diversity, Equity & Inclusion, including health disparities trials that engage community-based organizations
|
 | By Lineus Medical Lineus Medical announces the publication of a pivotal clinical study performed at Hartford Hospital, part of Hartford HealthCare in Hartford, Connecticut, in the March edition of The Journal of Infusion Nursing.
|
 | By aiaTranslations aiaTranslations, full-service provider of global language support, translations and interpreting services for life sciences, healthcare, medical and pharmaceutical industries' is now ISO certified.
|
By Cures Within Reach Cures Within Reach selecting at least 10 clinical trials to address health disparities and empower underrepresented researchers in the US and LMICs
|
